PapersFlow Research Brief
Congenital Heart Disease Studies
Research Guide
What is Congenital Heart Disease Studies?
Congenital Heart Disease Studies is the body of research examining the epidemiology, management, and outcomes of congenital heart disease, including cardiac surgery, pulmonary valve replacement, neurodevelopmental outcomes, adult congenital heart disease, mortality risk, fetal cardiac disease, ventricular function, echocardiogram guidelines, and the Fontan procedure.
The field encompasses 135,580 published works focused on congenital heart disease across the lifespan. Key areas include incidence rates, surgical interventions like the Fontan procedure, and long-term survival in adults. Studies also address global birth prevalence and associated burdens from population-based analyses.
Topic Hierarchy
Research Sub-Topics
Adult Congenital Heart Disease
Adult congenital heart disease research addresses long-term management, complications, and outcomes in adults with repaired or unrepaired CHD. Studies cover arrhythmias, heart failure, and pregnancy risks.
Fontan Procedure
Fontan procedure studies evaluate this palliative surgery for single ventricle defects, focusing on circulation, thrombosis, and protein-losing enteropathy. Research optimizes patient selection and long-term management.
Neurodevelopmental Outcomes CHD
Neurodevelopmental outcomes research examines cognitive, behavioral, and motor deficits in CHD survivors, linked to cyanosis, surgery, and genetics. Interventions target early screening and support.
Fetal Cardiac Disease
Fetal cardiac disease focuses on prenatal diagnosis, counseling, and fetal interventions for congenital heart defects using echocardiography. Studies assess natural history and pregnancy management.
Pulmonary Valve Replacement
Pulmonary valve replacement research compares surgical and transcatheter approaches post-repair in tetralogy of Fallot and similar lesions. Outcomes include right ventricular function and durability.
Why It Matters
Congenital Heart Disease Studies inform clinical guidelines and surgical practices that improve survival rates post-interventions such as the Fontan procedure, as detailed in Fontán and Baudet (1971) who reported successful repairs in two of three tricuspid atresia patients by redirecting vena caval blood to the lungs. Population-based research like van der Linde et al. (2011) established a worldwide birth prevalence of congenital heart disease at varying rates across regions, enabling targeted public health strategies. Recent NIH funding, including an $8.5 million grant renewal to Mount Sinai Health System, supports investigations into long-term outcomes in children, while ACHA has invested over $500,000 in 18 grants since 2019 to advance CHD research. These efforts directly impact management of adult congenital heart disease, as outlined in Baumgartner et al. (2010) ESC Guidelines.
Reading Guide
Where to Start
'The incidence of congenital heart disease' by Hoffman and Kaplan (2002) serves as the starting point for beginners, offering foundational epidemiological data essential for understanding prevalence before advancing to management studies.
Key Papers Explained
Hoffman and Kaplan (2002) in 'The incidence of congenital heart disease' establishes baseline prevalence, which van der Linde et al. (2011) extend globally in 'Birth Prevalence of Congenital Heart Disease Worldwide'. Fontán and Baudet (1971) introduce the Fontan procedure in 'Surgical repair of tricuspid atresia', a technique underpinning adult care addressed in Baumgartner et al. (2010) 'ESC Guidelines for the management of grown-up congenital heart disease'. Galiè et al. (2015) build on these with pulmonary hypertension guidelines in '2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension', relevant to post-surgical complications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints analyze global burden trends from 1990-2021 with projections to 2050, including 'Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050' by Erdengqieqieke Ye. NIH grants like the $8.5 million to Mount Sinai target long-term pediatric outcomes. GitHub projects apply deep learning for CHD detection via ECG and PCG signals.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Heart Disease and Stroke Statistics—2012 Update | 2011 | Circulation | 7.2K | ✓ |
| 2 | 2015 ESC/ERS Guidelines for the diagnosis and treatment of pul... | 2015 | European Heart Journal | 6.9K | ✓ |
| 3 | The incidence of congenital heart disease | 2002 | Journal of the America... | 6.0K | ✕ |
| 4 | Burden of valvular heart diseases: a population-based study | 2006 | The Lancet | 4.7K | ✕ |
| 5 | Updated Clinical Classification of Pulmonary Hypertension | 2013 | Journal of the America... | 4.2K | ✕ |
| 6 | Birth Prevalence of Congenital Heart Disease Worldwide | 2011 | Journal of the America... | 3.2K | ✕ |
| 7 | Percutaneous Transcatheter Implantation of an Aortic Valve Pro... | 2002 | Circulation | 3.1K | ✓ |
| 8 | Surgical repair of tricuspid atresia | 1971 | Thorax | 2.8K | ✓ |
| 9 | Transient Regenerative Potential of the Neonatal Mouse Heart | 2011 | Science | 2.5K | ✓ |
| 10 | ESC Guidelines for the management of grown-up congenital heart... | 2010 | European Heart Journal | 2.3K | ✓ |
In the News
Mount Sinai Health System Receives $8.5 Million NIH Grant Renewal to Advance Research on Long-Term Outcomes in Children With Congenital Heart Disease
The National Institutes of Health has awarded the Icahn School of Medicine at Mount Sinai an $8.5 million renewal grant to continue groundbreaking work aimed at understanding andimprovinglong-termo...
New $8.5 million renewal grant fuels research on children's ...
The National Institutes of Health has awarded the Icahn School of Medicine at Mount Sinai an $8.5 million renewal grant to continue groundbreaking work aimed at understanding and improving long-ter...
Research grants awarded to advance understanding of no. ...
Researchers studying the prevention and treatment of CHDs are encouraged to submit applications for funding from the American Heart Association and The Children’s Heart Foundation. For submission g...
$3.2M NIH grant to test and refine a heart pump for long- ...
Heart failure in children is often the result of congenital heart disease, where heart problems are present from birth, explained the research team. For these patients, the wait for a transplant ca...
CHD Research - ACHA
## ACHA has invested more than $500,000 to 18 grants in our emerging research program since it launched in 2019. #### ACHA Research Grant Applications Now Available
Code & Tools
Make sure you have the following installed: Python 3.8+ Jupyter Notebook / JupyterLab Common scientific libraries: numpy pandas scik...
Scripts and modules for training and testing deep neural networks that conducts congenital heart disease detection using electrocardiogram (ECG).
# Search code, repositories, users, issues, pull requests... Search Clear Search syntax tips # Provide feedback We read every piece of feedba...
This research presents an innovative approach to automatically detect Congenital Heart Diseases (CHDs) in pediatric patients using Phonocardiogram ...
2. Retrieve confidence scoring for congenital heart disease prompt questions using an article's abstract result section to reduce hallucinations.
Recent Preprints
Global Burden of Pediatric Cardiovascular Diseases of Congenital and Non-Congenital Trends from 1992 to 2021
This study examined global trends in heart diseases among children and adolescents from 1992 to 2021, focusing on congenital heart disease (CHD, present at birth) and non-congenital cardiovascular ...
Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Previous congenital heart disease estimates came from few data sources, were geographically narrow, and did not evaluate congenital heart disease throughout the life course. Completed as part of Gl...
Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050
# Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050 Erdengqieqieke Ye ### Erdengqieqieke Ye 1Department of Prenatal Diagnosis, Rep...
Disparities in disease burden of congenital heart ...
Congenital heart disease (CHD) has severe impact on people’s health status and disease burden worldwide. Little is known about the disparities of the CHD burden in the western China. We aimed to an...
Neurodevelopment in congenital heart disease: a review of antenatal mechanisms and therapeutic potentials
Improvements in treatment and survival of neonates with complex congenital heart disease have led to growing recognition of the associated neurodevelopmental impairments. In this review, we explore...
Latest Developments
Recent research highlights ongoing efforts to improve diagnosis, treatment, and management of congenital heart disease, including advances in fetal diagnosis, genetic understanding, and clinical guidelines for adult patients, with studies exploring new surgical approaches, genetic factors like DYRK1A, and the development of specialized care protocols as of early 2026 (NYU Langone, Nature, American Heart Association).
Sources
Frequently Asked Questions
What is the incidence of congenital heart disease?
Hoffman and Kaplan (2002) calculated the incidence of congenital heart disease through a comprehensive review. Their analysis in 'The incidence of congenital heart disease' provides foundational population-based estimates. These figures remain widely referenced for epidemiological planning.
What is the worldwide birth prevalence of congenital heart disease?
van der Linde et al. (2011) determined the birth prevalence of congenital heart disease worldwide in 'Birth Prevalence of Congenital Heart Disease Worldwide'. The study synthesized global data to report region-specific rates. This enables cross-country comparisons of disease burden.
What does the Fontan procedure involve?
Fontán and Baudet (1971) described surgical repair of tricuspid atresia in 'Surgical repair of tricuspid atresia'. The procedure directs all vena caval blood to the lungs while oxygenated blood returns to the left heart. It achieved success in two of three patients reported.
How are guidelines for adult congenital heart disease established?
Baumgartner et al. (2010) issued ESC Guidelines in 'ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)'. These summarize evidence for management strategies considering patient outcomes. The guidelines assist physicians in individualized care.
What is the focus of pulmonary hypertension guidelines relevant to congenital heart disease?
Galiè et al. (2015) provided ESC/ERS Guidelines in '2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension'. These cover diagnosis and treatment applicable to congenital heart disease cases with pulmonary involvement. The document includes recommendations from multiple reviewers.
What are key neurodevelopmental concerns in congenital heart disease?
Neurodevelopmental outcomes form a core topic in Congenital Heart Disease Studies. Recent preprints like 'Neurodevelopment in congenital heart disease: a review of antenatal mechanisms and therapeutic potentials' examine antenatal hypoxia and genetic factors. These impairments affect long-term survivor quality of life.
Open Research Questions
- ? What are the long-term neurodevelopmental trajectories in survivors of complex congenital heart surgeries like the Fontan procedure?
- ? How do regional disparities in congenital heart disease burden, such as those in western China, influence equity in access to care?
- ? What antenatal mechanisms, including hypoxia and placental factors, contribute to brain development alterations in fetal cardiac disease?
- ? Can machine learning models accurately detect congenital heart disease from pediatric ECG or PCG signals in clinical settings?
- ? What projections for congenital heart anomaly burdens to 2050 reveal about future global healthcare needs?
Recent Trends
Global Burden of Disease analyses in preprints track congenital heart disease trends from 1990-2021, highlighting pediatric cardiovascular burdens in 'Global Burden of Pediatric Cardiovascular Diseases of Congenital and Non-Congenital Trends from 1992 to 2021'. Disparities by sex, age, and ethnicity emerge in western China per 'Disparities in disease burden of congenital heart ...'. NIH awarded $8.5 million renewal to Mount Sinai for long-term outcomes and $3.2M for heart pumps in CHD-related failure.
2026ACHA invested over $500,000 in 18 grants since 2019.
Research Congenital Heart Disease Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Congenital Heart Disease Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers